These proteins are highly involved in the progressive degeneration of dopaminergic system as reported in many neurodegenerative diseases [88]. Accordingly, cands can penetrate blood brain barrier (BBB) and modulate 3-NP-induced HD symptoms via inhibiting the stimulating action of Ang II on dopamine receptors, preventing neuronal cell death [89]. This evidence concerns the gene AGT and Huntington disease.